CHM 4.17% 1.2¢ chimeric therapeutics limited

25m not enough, page-3

  1. 478 Posts.
    In some ways chm is in the better negotiating position given MMX deadline.

    But it is also CHM deadline as unless the court ruling is completely in CHM favour - ie they get dirt - not a share of MMX profit, then if MMX loses Oakagee then CHM also loses any chance of a decent sum.

    If CHM asks too much then MMX Sh may reject and everyone loses.

    A lot may depend on when the judges get their act together

    If CHM wins dirt then they can have a big payment
    If not they must deal with MMX
    IMO only
    Rumot

    PS BTW MM2 you were right
 
watchlist Created with Sketch. Add CHM (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.